Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-25

Clinical Trial Update: Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating safety and efficacy of an oral full-spectrum medicinal cannabis plant extract in children with autism spectrum disorder (Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenix Innovation Group oral full-spectrum medicinal cannabis plant extract

Snippet

Sponsor: Fenix Innovation Group | Conditions: Autism Spectrum Disorder | Phase 1, Phase 2 | Status: UNKNOWN